LEXEO Therapeutics Company
LEXEO Therapeutics is a biotechnology company.
Investors
Industry:
Clinical Development, Early Drug Development, Preclinical Development
Headquarters:
New York, New York, United States
Founded Date:
2018-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
16
Total Funding:
185000000
Estimated Revenue:
$1M to $10M
Last Funding Date:
2021-09-09
Last Funding Type:
Series B
Register and Claim Ownership